CAROL ROMANO: Open Payments
NPI 1265426696 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 14 payments from 9 companies in 2025. Trend: 2023 $217 · 2024 $123 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| CVRx, Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Kestra Medical Technology Services, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: LEQVIO, Barostim Neo System, VERQUVO, Assure WCD, Wegovy, JARDIANCE, REPATHA, ELIQUIS.
Industry payments across NC — which companies pay providers there.
